APA (7th ed.) Citation

Ozkerim, U., Kinikoglu, O., Isik, D., Altintas, Y. E., Ay Ersoy, S., Surmeli, H., . . . Turan, N. (2026). Association Between Time to PSA Nadir, Radiologic Progression, and PSA Progression in mHSPC Patients Treated with Abiraterone or Enzalutamide. Journal of Clinical Medicine, 15(1), 386. https://doi.org/10.3390/jcm15010386

Chicago Style (17th ed.) Citation

Ozkerim, Ugur, Oguzcan Kinikoglu, Deniz Isik, Yunus Emre Altintas, Seval Ay Ersoy, Heves Surmeli, Hatice Odabas, Tugba Basoglu, and Nedim Turan. "Association Between Time to PSA Nadir, Radiologic Progression, and PSA Progression in MHSPC Patients Treated with Abiraterone or Enzalutamide." Journal of Clinical Medicine 15, no. 1 (2026): 386. https://doi.org/10.3390/jcm15010386.

MLA (9th ed.) Citation

Ozkerim, Ugur, et al. "Association Between Time to PSA Nadir, Radiologic Progression, and PSA Progression in MHSPC Patients Treated with Abiraterone or Enzalutamide." Journal of Clinical Medicine, vol. 15, no. 1, 2026, p. 386, https://doi.org/10.3390/jcm15010386.